Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection
Authors:
- Matt A PriceMPMatt A Price
- Wasima RidaWRWasima Rida
- Eugene RuzagiraEREugene Ruzagira
Open Access
- 2 April 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 220 (3) , 432-441
Abstract
Few human immunodeficiency virus (HIV)–infected persons can maintain low viral levels without therapeutic intervention. We evaluate predictors of spontaneous control of the viral load (hereafter, “viral control”) in a prospective cohort of African adults shortly after HIV infection. Viral control was defined as ≥2 consecutively measured viral loads (VLs) of ≤10 000 copies/mL after the estimated date of infection, followed by at least 4 subsequent measurements for which the VL in at least 75% was ≤10 000 copies/mL in the absence of ART. Multivariable logistic regression characterized predictors of viral control. Of 590 eligible volunteers, 107 (18.1%) experienced viral control, of whom 25 (4.2%) maintained a VL of 51–2000 copies/mL, and 5 (0.8%) sustained a VL of ≤50 copies/mL. The median ART-free follow-up time was 3.3 years (range, 0.3–9.7 years). Factors independently associated with control were HIV-1 subtype A (reference, subtype C; adjusted odds ratio [aOR], 2.1 [95% confidence interval {CI}, 1.3–3.5]), female sex (reference, male sex; aOR, 1.8 [95% CI, 1.1–2.8]), and having HLA class I variant allele B*57 (reference, not having this allele; aOR, 1.9 [95% CI, 1.0–3.6]) in a multivariable model that also controlled for age at the time of infection and baseline CD4+ T-cell count. We observed strong associations between infecting HIV-1 subtype, HLA type, and sex on viral control in this cohort. HIV-1 subtype is important to consider when testing and designing new therapeutic and prevention technologies, including vaccines.Keywords
Funding Information
- International AIDS Vaccine Initiative
This publication has 35 references indexed in Scilit:
- CD8 + T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I AllelesJournal of Virology, 2016
- Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and TransmissionPLOS ONE, 2015
- A systematic review of definitions of extreme phenotypes of HIV control and progressionAIDS, 2014
- The implications of viral reservoirs on the elite control of HIV-1 infectionCellular and Molecular Life Sciences, 2012
- Transmitted HIV Type 1 Drug Resistance Among Individuals with Recent HIV Infection in East and Southern AfricaAIDS Research and Human Retroviruses, 2011
- Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History StudyThe Journal of Infectious Diseases, 2009
- Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysisAIDS, 2009
- Epidemiologic Characteristics and Natural History of HIV-1 Natural Viral SuppressorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Les « HIV controllers » : un groupe homogène de patients infectés par le VIH avec un contrôle spontané de la réplication viralePathologie Biologie, 2006
- Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in AfricaAIDS Research and Human Retroviruses, 2001